SOLIGENIX INC (SNGX:NASDAQ)
$0.8157 -0.05 (-5.7757%)
Analysed SOLIGENIX INC (SNGX:NASDAQ) News Sources
Soligenix (SNGX) Advances CTCL Research With Interim Analysis, Comparative Study Results
17-04-2026
yahoo.com
Soligenix (SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status
20-04-2026
yahoo.com
Soligenix (SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach
21-04-2026
yahoo.com
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
28-04-2026
yahoo.com
SNGX Phase 3 Trial Halted on HyBryte
28-04-2026
advfn.com
SNGX: FLASH2 Trial Recommended to Stop for Futility
29-04-2026
yahoo.com
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
08-05-2026
yahoo.com
SNGX: Continuing to Analyze FLASH2 Data
14-05-2026
yahoo.com
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
26-05-2026
yahoo.com
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month – Ebola Vaccine Optimism Fuels Retail Frenzy
27-05-2026
stocktwits.com
What is the current price of SOLIGENIX INC (SNGX:NASDAQ)?
The current price of SOLIGENIX INC (SNGX:NASDAQ) is $0.8157.
SOLIGENIX INC (SNGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SOLIGENIX INC (SNGX:NASDAQ) since the previous trading day is $-0.05.
SOLIGENIX INC (SNGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SOLIGENIX INC (SNGX:NASDAQ) since the previous trading day is -5.7757%.
What is the most recent average sentiment score for SOLIGENIX INC (SNGX:NASDAQ)?
The most recent average sentiment score for SOLIGENIX INC (SNGX:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for SOLIGENIX INC (SNGX:NASDAQ)?
The most recent sentiment for SOLIGENIX INC (SNGX:NASDAQ) is .
SEC-8K** Filing Available For SOLIGENIX INC (SNGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.